Sildenafil Tablet, Film Coated
Product Images NDC 68071-3745

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 68071-3745). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Pdp (68071 3745 6)

Pdp (68071 3745 6)
FDA Label Image

Figure 1 (Sildenafil Fig1)

Figure 1 (Sildenafil Fig1)
This text provides information about the change in sitting systolic blood pressure of healthy volunteers after taking 100mg of Sildenafil or a placebo. The measurements were taken both before and after the dose administration.*
FDA Label Image

Figure 2 (Sildenafil Fig2)

Figure 2 (Sildenafil Fig2)
This text provides a graph showing the change in systolic blood pressure (SBP) in mmHg over time post-dose for two treatment groups: one receiving Doxazosin + Placebo and the other receiving Doxazosin + Sildenafil 25 mg. The data in the graph displays the SBP change from baseline at different hours post-dose.*
FDA Label Image

Figure 3 (Sildenafil Fig3)

Figure 3 (Sildenafil Fig3)
FDA Label Image

Figure 4 (Sildenafil Fig4)

Figure 4 (Sildenafil Fig4)
This text provides information about a study comparing the effects of Doxazosin + Sildenafil 100 mg versus Doxazosin + Placebo on mean standing systolic blood pressure change from baseline over time after dosing.*
FDA Label Image

Figure 5 (Sildenafil Fig5)

Figure 5 (Sildenafil Fig5)
This is a graph showing the mean sildenafil plasma concentrations in healthy male volunteers over time after the administration of a commercial tablet. The data is displayed at different time points post-dose, ranging from 2 to 24 hours.*
FDA Label Image

Figure 6. Effect Of Sildenafil And Placebo On Maintenance Of Erection By Baseline Score (Sildenafil Fig6)

Figure 6. Effect Of Sildenafil And Placebo On Maintenance Of Erection By Baseline Score (Sildenafil Fig6)
FDA Label Image

Sildenafile Fig 7 (Sildenafil Fig7)

Sildenafile Fig 7 (Sildenafil Fig7)
FDA Label Image

Structure (Sildenafil Str)

Structure (Sildenafil Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.